Stock Market Analysis Archives - Page 27 of 919

Pound Rebounds as UK Growth Data Surprises, Euro Faces Pressure

The forex market reacts as the GBP recovers, the EUR faces pressure, and the USD remains strong amid evolving economic landscapes.

The Euro struggles as energy prices rise, while the USD gains ground backed by strong economic data.

Shareholder pushback is complicating Alcon’s acquisition of STAAR Surgical, raising concerns about valuation and strategic alignment.

Citius Oncology has partnered with McKesson to improve distribution of lymphoma therapy, aiming for better accessibility and market presence.

BMO Capital has reduced its price target for Travelers (TRV) to $297, citing concerns over growth deceleration and its potential impact on investors.

Corbus Pharmaceuticals saw a stock surge after announcing positive data for CRB-701, an innovative cancer treatment.

Palisade Bio initiates a clinical trial targeting fibrostenotic Crohn’s disease, exploring innovative treatment options and potential market impacts.

TGE has announced a 160% increase in revenue, largely due to its growing hospitality sector. This article explores the factors driving this growth.

BMO Capital has raised its price target for AbbVie to $258, reflecting the company’s strong pipeline and market position.

Colombia has recalled its U.S. ambassador due to tariff and drug policy issues, signaling heightened diplomatic tensions between the two nations.